NASDAQ:BCPCBalchem Stock Price, Forecast & News

$100.65

+0.37 (+0.37 %)

(As of 05/29/2020 04:00 PM ET)

Add

Compare

Today's Range

$97.39

Now: $100.65▼

$101.58

50-Day Range

$80.30

MA: $92.19▼

$102.08

52-Week Range

$78.30

Now: $100.65▼

$113.93

Volume175,454 shs

Average Volume194,234 shs

Market Capitalization$3.25 billion

P/E Ratio40.42

Dividend Yield0.52%

Beta0.59

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include creamer and chocolate systems, dairy replacers, powdered fats, nutritional beverage bases, beverages, juice and dairy bases, ice cream bases and variegates, cereals, grain based snacks, and cereal based ingredients. This segment also offers microencapsulation solutions; and human grade choline nutrients and mineral amino acid chelated products for wellness applications. Its Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The company's Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. It also sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company's Industrial Products segment provides choline chloride derivatives for hydraulic fracturing of shale natural gas wells; and methylamines, which are building blocks for the manufacture of choline products, as well as used in industrial applications. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was founded in 1967 and is headquartered in New Hampton, New York.

Beat the Market (BTM) Rank^™

1.5 Analyst's Opinion

Consensus Rating
Balchem has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $104.00, Balchem has a potential upside of 3.3% from its current price of $100.65.
Amount of Analyst Coverage
Balchem has only been the subject of 1 research reports in the past 90 days.

2.7 Community Rank

Outperform Votes
Balchem has received 354 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Balchem has received 310 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Balchem has received 53.31% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Balchem and other stocks. Vote “Outperform” if you believe BCPC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe BCPC will underperform the S&P 500 over the long term. You may vote once every thirty days.

4.2 Dividend Strength

Dividend Leadership
Balchem is a leading dividend payer. It pays a dividend yield of 0.52%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
Balchem has been increasing its dividend for 9 years.
Dividend Coverage
The dividend payout ratio of Balchem is 16.30 %. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Balchem will have a dividend payout ratio of 17.63 % next year. This indicates that Balchem will be able to sustain or increase its dividend.

1.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Balchem insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 1.28% of the stock of Balchem is held by insiders.
Percentage Held by Institutions
86.12% of the stock of Balchem is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6 Earnings and Valuation

Earnings Growth
Earnings for Balchem are expected to grow by 14.34% in the coming year, from $2.58 to $2.95 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Balchem is 40.42, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 14.61.
Price to Earnings Ratio vs. Sector
The P/E ratio of Balchem is 40.42, which means that it is trading at a more expensive P/E ratio than the Basic Materials sector average P/E ratio of about 21.63.
Price to Book Value per Share Ratio
Balchem has a P/B Ratio of 4.25. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

2.00 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Chemicals & allied products

Sub-IndustrySpecialty Chemicals

SectorBasic Materials

Current SymbolNASDAQ:BCPC

Previous Symbol

CUSIP05766520

CIK9326

Webwww.balchem.com

Phone845-326-5600

Debt

Debt-to-Equity Ratio0.35

Current Ratio3.77

Quick Ratio2.61

Price-To-Earnings

Trailing P/E Ratio40.42

Forward P/E Ratio39.01

P/E GrowthN/A

Sales & Book Value

Annual Sales$643.71 million

Price / Sales5.05

Cash Flow$4.67 per share

Price / Cash Flow21.57

Book Value$23.71 per share

Price / Book4.25

Profitability

EPS (Most Recent Fiscal Year)$3.19

Net Income$79.67 million

Net Margins12.20%

Return on Equity14.30%

Return on Assets9.43%

Miscellaneous

Employees1,424

Outstanding Shares32,320,000

Market Cap$3.25 billion

Next Earnings Date8/6/2020 (Estimated)

OptionableOptionable

Receive BCPC News and Ratings via Email

Sign-up to receive the latest news and ratings for BCPC and its competitors with MarketBeat's FREE daily newsletter.

Balchem (NASDAQ:BCPC) Frequently Asked Questions

How has Balchem's stock been impacted by COVID-19 (Coronavirus)?

Balchem's stock was trading at $89.29 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BCPC stock has increased by 12.7% and is now trading at $100.65. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Balchem?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Balchem in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Balchem.

When is Balchem's next earnings date?

Balchem is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Balchem.

How were Balchem's earnings last quarter?

Balchem Co. (NASDAQ:BCPC) issued its earnings results on Friday, May, 1st. The basic materials company reported $0.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.59 by $0.22. The basic materials company earned $174.44 million during the quarter, compared to analyst estimates of $169.87 million. Balchem had a net margin of 12.20% and a return on equity of 14.30%. The firm's revenue was up 11.1% compared to the same quarter last year. During the same period in the previous year, the company earned $0.73 EPS. View Balchem's earnings history.

How often does Balchem pay dividends? What is the dividend yield for Balchem?

Balchem announced an annual dividend on Wednesday, December 18th. Shareholders of record on Monday, December 30th will be paid a dividend of $0.52 per share on Friday, January 17th. This represents a yield of 0.51%. The ex-dividend date of this dividend is Friday, December 27th. This is an increase from Balchem's previous annual dividend of $0.47. View Balchem's dividend history.

What price target have analysts set for BCPC?

1 equities research analysts have issued twelve-month target prices for Balchem's shares. Their forecasts range from $104.00 to $104.00. On average, they expect Balchem's stock price to reach $104.00 in the next twelve months. This suggests a possible upside of 3.3% from the stock's current price. View analysts' price targets for Balchem.

Has Balchem been receiving favorable news coverage?

Press coverage about BCPC stock has trended somewhat negative this week, according to InfoTrie. The research firm identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Balchem earned a media sentiment score of -1.1 on InfoTrie's scale. They also assigned media coverage about the basic materials company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news aboutBalchem.

Are investors shorting Balchem?

Balchem saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 510,100 shares, a decline of 6.3% from the April 30th total of 544,300 shares. Based on an average daily trading volume, of 155,300 shares, the short-interest ratio is presently 3.3 days. Approximately 1.6% of the shares of the company are short sold. View Balchem's Current Options Chain.

Who are some of Balchem's key competitors?

Some companies that are related to Balchem include Ecolab (ECL), Sherwin-Williams (SHW), International Flavors & Fragrances (IFF), Celanese (CE), RPM International (RPM), Albemarle (ALB), NewMarket (NEU), Ashland Global (ASH), W. R. Grace & Co (GRA), Quaker Chemical (KWR), PolyOne (POL), Stepan (SCL), Sensient Technologies (SXT), HB Fuller (FUL) and Innospec (IOSP). View all competitors.

What other stocks do shareholders of Balchem own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Balchem investors own include Gilead Sciences (GILD), AbbVie (ABBV), CVS Health (CVS), Ecolab (ECL), Adobe (ADBE), Mastercard (MA), Altria Group (MO), NVIDIA (NVDA), Pfizer (PFE) and Starbucks (SBUX).

Who are Balchem's key executives?

Balchem's management team includes the following people:

Mr. Theodore L. Harris, Chairman and Chief Exec. Officer (Age 54)
Mr. William A. Backus CPA, Chief Accounting Officer (Age 53)
Mr. Mark A. Stach, Gen. Counsel & Corp. Sec.
Mr. David F. Ludwig, VP & Gen. Mang. of Industrial Products (Age 61)
Mr. Carl Martin Bengtsson, Chief Financial Officer

What is Balchem's stock symbol?

Balchem trades on the NASDAQ under the ticker symbol "BCPC."

Who are Balchem's major shareholders?

Balchem's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (14.34%), Brown Capital Management LLC (10.52%), Wasatch Advisors Inc. (3.61%), State Street Corp (3.08%), Conestoga Capital Advisors LLC (2.63%) and Fred Alger Management LLC (2.05%). Company insiders that own Balchem stock include Daniel E Knutson, David F Ludwig and Scott C Mason. View institutional ownership trends for Balchem.

Which institutional investors are selling Balchem stock?

BCPC stock was sold by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., BlackRock Inc., Morgan Stanley, Morgan Stanley, GW&K Investment Management LLC, Brown Capital Management LLC, Atlanta Capital Management Co. L L C, and Horizon Kinetics Asset Management LLC. View insider buying and selling activity for Balchem.

Which institutional investors are buying Balchem stock?

BCPC stock was acquired by a variety of institutional investors in the last quarter, including Schroder Investment Management Group, Personal Capital Advisors Corp, State Street Corp, Wells Fargo & Company MN, Conestoga Capital Advisors LLC, Geode Capital Management LLC, Cutter & CO Brokerage Inc., and Nuveen Asset Management LLC. Company insiders that have bought Balchem stock in the last two years include Daniel E Knutson, and Scott C Mason. View insider buying and selling activity for Balchem.

How do I buy shares of Balchem?

Shares of BCPC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Balchem's stock price today?

One share of BCPC stock can currently be purchased for approximately $100.65.

How big of a company is Balchem?

Balchem has a market capitalization of $3.25 billion and generates $643.71 million in revenue each year. The basic materials company earns $79.67 million in net income (profit) each year or $3.19 on an earnings per share basis. Balchem employs 1,424 workers across the globe.

What is Balchem's official website?

The official website for Balchem is www.balchem.com.

How can I contact Balchem?

Balchem's mailing address is 52 Sunrise Park Road, NEW HAMPTON NY, 10958. The basic materials company can be reached via phone at 845-326-5600 or via email at [email protected]

This page was last updated on 5/30/2020 by MarketBeat.com Staff